BIOMARKERS OF THE CHANCES OF SURVIVAL OF A PATIENT WITH AML

FR3155832A1Inactive Publication Date: 2025-05-30UNIVERSITE GRENOBLE ALPES +3
5 Cites 0 Cited by

Patent Information

Application Number
FR2024011079
Authority / Receiving Office
FR · FR
Patent Type
Applications
Current Assignee / Owner
Filing Date
2024-10-14
Publication Date
2025-05-30
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The present invention relates to a method for in vitro or ex vivo diagnosis of the chances of survival of a patient suffering from Acute Myeloid Leukemia (AML) comprising a step of detecting the expression of newly identified AML biomarker genes.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Application of adenylosuccinate synthetase and / or protein encoded thereby

    CN110124038A

  • Classification of Acute Myeloid Leukemia

    US20090118132A1

  • Markers for the diagnosis of AML, b-all and t-all

    US20120015845A1

  • Markers for MLL-rearranged acute myeloid leukemias and uses thereof

    WO2016141492A1

  • A method of treating acute myeloid leukemia

    WO2023101608A2